Evelo Biosciences, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2997342025
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
-4.99
8.67
30.48
60.20
136.95
28.98
Shareholder's Funds
-4.99
8.67
30.48
60.20
136.95
28.98
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
45.87
48.51
31.72
19.63
12.30
9.97
Secured Loans
45.87
48.51
31.72
19.63
12.30
9.97
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
13.42
15.29
10.27
1.35
1.38
1
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
57.04
61.84
37.69
20.98
13.68
10.97
Current Liabilities
Trade Payables
1.76
1.60
1.44
0.62
1.52
1.41
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
12.39
17.36
22.46
9.74
9.23
3.84
Total Liabilities
64.44
87.87
90.64
90.92
159.87
43.79
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
21.05
23.17
23.88
12.05
8.88
4.92
Less: Accumulated Depreciation
9.34
7.63
5.64
3.71
1.95
1.43
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
11.71
15.53
18.23
8.34
6.92
3.50
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
1.20
1.30
1.30
1.50
1.25
1.50
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
-0.04
0.01
0.12
0.07
0.07
0.01
Total Non-Current Assets
12.87
16.84
19.66
9.91
8.24
5.01
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
54.82
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
0.00
0.00
0.00
Cash and Bank
47.94
68.44
68.86
77.83
93.10
38.25
Other Current Assets
47.94
68.44
68.86
77.83
147.92
38.25
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
51.57
71.03
70.98
81.01
151.62
38.78
Net Current Assets (Including Current Investments)
39.18
53.66
48.52
71.27
142.39
34.94
Total Current Assets Excluding Current Investments
51.57
71.03
70.98
81.01
151.62
38.78
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
64.44
87.87
90.64
90.92
159.87
43.79
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
45.87
48.51
31.72
19.63
12.30
9.97
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2022 is -6.34% vs 69.80% in Dec 2021

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2022 is -12.23% vs 48.88% in Dec 2021

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2022 is -24.60% vs -14.81% in Dec 2021

stock-summary

Investments

YoY Growth in year ended Dec 2022 is -7.69% vs 0.00% in Dec 2021

stock-summary

Current Assets

YoY Growth in year ended Dec 2022 is -27.40% vs 0.07% in Dec 2021

Compare Balance Sheet Results of Evelo Biosciences, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
-4.99
82.39
-87.38
-106.06%
Shareholder's Funds
-4.99
82.39
-87.38
-106.06%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
45.87
15.29
30.58
200.00%
Secured Loans
45.87
15.29
30.58
200.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0.83
-0.83
-100.00%
Other Long Term Liabilities
13.42
15.72
-2.30
-14.63%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
57.04
25.16
31.88
126.71%
Current Liabilities
Trade Payables
1.76
0.82
0.94
114.63%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
12.39
11.21
1.18
10.53%
Total Liabilities
64.44
118.77
-54.33
-45.74%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
21.05
73.76
-52.71
-71.46%
Less: Accumulated Depreciation
9.34
12.24
-2.90
-23.69%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
11.71
61.52
-49.81
-80.97%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
1.20
0
1.20
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
-0.04
1.38
-1.42
-102.90%
Total Non-Current Assets
12.87
75.99
-63.12
-83.06%
Current Assets Loans & Advances
Current Investments
0
26.69
-26.69
-100.00%
Inventories
0
6.80
-6.80
-100.00%
Sundry Debtors
0
4.31
-4.31
-100.00%
Cash and Bank
47.94
3.71
44.23
1,192.18%
Other Current Assets
47.94
41.51
6.43
15.49%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
51.57
42.78
8.79
20.55%
Net Current Assets (Including Current Investments)
39.18
31.57
7.61
24.11%
Total Current Assets Excluding Current Investments
51.57
42.78
8.79
20.55%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
64.44
118.77
-54.33
-45.74%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
45.87
15.29
30.58
200.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 43.61 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -6.34% vs 69.80% in Dec 2021

Annual - Other Long Term Liabilities
Other Long Term Liabilities 13.42 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -12.23% vs 48.88% in Dec 2021

Annual - Fixed Assets
Fixed Assets 11.71 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -24.60% vs -14.81% in Dec 2021

Annual - Investments
Investments 1.20 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -7.69% vs 0.00% in Dec 2021

Annual - Current Assets
Current Assets 51.57 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -27.40% vs 0.07% in Dec 2021